Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0224 | 0.3228 | 1 |
Mycobacterium ulcerans | putative transglutaminase-like protein | 0.0224 | 0.3228 | 0.5 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0224 | 0.3228 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0224 | 0.3228 | 0.5 |
Brugia malayi | Thioredoxin family protein | 0.0224 | 0.3228 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0224 | 0.3228 | 0.5 |
Mycobacterium ulcerans | transglutaminase family protein | 0.0224 | 0.3228 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.0224 | 0.3228 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0224 | 0.3228 | 0.5 |
Mycobacterium tuberculosis | Long conserved protein | 0.0224 | 0.3228 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0224 | 0.3228 | 0.5 |
Echinococcus granulosus | adam 17 protease | 0.0223 | 0.3204 | 0.9926 |
Onchocerca volvulus | 0.0224 | 0.3228 | 0.5 | |
Giardia lamblia | Transglutaminase/protease, putative | 0.0224 | 0.3228 | 0.5 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0224 | 0.3228 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0224 | 0.3228 | 0.5 |
Echinococcus multilocularis | adam 17 protease | 0.0203 | 0.2528 | 0.7831 |
Trichomonas vaginalis | peptide N-glycanase, putative | 0.0224 | 0.3228 | 0.5 |
Echinococcus granulosus | Transglutaminase | 0.0224 | 0.3228 | 1 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0224 | 0.3228 | 0.5 |
Echinococcus multilocularis | Transglutaminase | 0.0224 | 0.3228 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.